Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1983 8
1984 60
1985 132
1986 274
1987 390
1988 374
1989 529
1990 502
1991 503
1992 527
1993 577
1994 537
1995 592
1996 572
1997 623
1998 648
1999 693
2000 681
2001 773
2002 754
2003 808
2004 822
2005 957
2006 945
2007 988
2008 1056
2009 1043
2010 1095
2011 1200
2012 1276
2013 1330
2014 1377
2015 1391
2016 1449
2017 1483
2018 1636
2019 1759
2020 1942
2021 2051
2022 2047
2023 1989
2024 1600
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

36,755 results

Results by year

Filters applied: . Clear all
Page 1
Ciprofloxacin derivatives and their antibacterial activities.
Zhang GF, Liu X, Zhang S, Pan B, Liu ML. Zhang GF, et al. Eur J Med Chem. 2018 Feb 25;146:599-612. doi: 10.1016/j.ejmech.2018.01.078. Epub 2018 Feb 4. Eur J Med Chem. 2018. PMID: 29407984 Review.
The emergency and widely spread of drug-resistant pathogens making ciprofloxacin more and more ineffective, so it's imperative to develop novel antibacterials. Numerous of ciprofloxacin derivatives have been synthesized for seeking for new antibacterials, and some o …
The emergency and widely spread of drug-resistant pathogens making ciprofloxacin more and more ineffective, so it's imperative to dev …
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.
Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, Heidary M, Khoshnood S. Shariati A, et al. Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
Ciprofloxacin's main mode of action is to stop DNA replication by blocking the A subunit of DNA gyrase and having an extra impact on the substances in cell walls. ...This review focuses on the resistance mechanisms of bacteria against ciprofloxacin and new ap …
Ciprofloxacin's main mode of action is to stop DNA replication by blocking the A subunit of DNA gyrase and having an extra imp …
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA, Ward A. Campoli-Richards DM, et al. Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003. Drugs. 1988. PMID: 3292209 Review.
Ciprofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic acid. ...Unlike most broad spectrum antibacterial drugs, ciprofloxacin is effective after oral or intravenous administration. Ciprofloxacin has been most exte …
Ciprofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic acid. ...Unlike most broad spect …
Ciprofloxacin.
Kulshrestha SP, Barar FS, Miglani N. Kulshrestha SP, et al. Indian Pediatr. 1990 Aug;27(8):849-53. Indian Pediatr. 1990. PMID: 2152246 Review. No abstract available.
Ciprofloxacin.
Terp DK, Rybak MJ. Terp DK, et al. Drug Intell Clin Pharm. 1987 Jul-Aug;21(7-8):568-74. doi: 10.1177/1060028087021007-801. Drug Intell Clin Pharm. 1987. PMID: 3301247 Review.
Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide variety of infections. In addition, extensive clinical trials with the intravenous preparation are underway. In vitro and in vivo studies with ciprofloxacin hav …
Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide variety of infections. In a …
Ciprofloxacin crystalluria.
Fogazzi GB, Garigali G, Brambilla C, Daudon M. Fogazzi GB, et al. Nephrol Dial Transplant. 2006 Oct;21(10):2982-3. doi: 10.1093/ndt/gfl320. Epub 2006 Jul 12. Nephrol Dial Transplant. 2006. PMID: 16837513 No abstract available.
[Ciprofloxacin-induced thrombopenia].
Santucci R, Bouayad-Agha K, Maloisel F, Couturier F. Santucci R, et al. Med Mal Infect. 2012 Apr;42(4):175-6. doi: 10.1016/j.medmal.2012.02.008. Epub 2012 Apr 3. Med Mal Infect. 2012. PMID: 22475418 French. No abstract available.
Does ciprofloxacin interact with cyclosporine?
Hoey LL, Lake KD. Hoey LL, et al. Ann Pharmacother. 1994 Jan;28(1):93-6. doi: 10.1177/106002809402800117. Ann Pharmacother. 1994. PMID: 8123970 Review.
Because ciprofloxacin may be used to treat a variety of infections in transplant recipients who receive cyclosporine, it is important to determine whether an interaction exists. Although cyclosporine is known to cause nephrotoxicity, only a few reports of ciprofloxacin …
Because ciprofloxacin may be used to treat a variety of infections in transplant recipients who receive cyclosporine, it is important …
Ciprofloxacin.
Sterman BM. Sterman BM. Laryngoscope. 1989 Nov;99(11):1211-2. doi: 10.1288/00005537-198911000-00022. Laryngoscope. 1989. PMID: 2811565 No abstract available.
Ciprofloxacin.
Smyth EG, Pallet AP. Smyth EG, et al. Br J Hosp Med. 1989 Jan;41(1):62, 66-7. Br J Hosp Med. 1989. PMID: 2924060
Ciprofloxacin is a useful, orally available, non-toxic broad-spectrum antibiotic. Despite its novel mode of action, resistance is arising and we feel the drug should be reserved for specific indications where it can be of enormous value....
Ciprofloxacin is a useful, orally available, non-toxic broad-spectrum antibiotic. Despite its novel mode of action, resistance is ari …
36,755 results
You have reached the last available page of results. Please see the User Guide for more information.